Tissue Regenix Group Overview

  • Founded
  • 2006
Founded
  • Status
  • Public
  • Employees
  • 77
Employees
  • Stock Symbol
  • TRX
Stock Symbol
  • Investments
  • 3

Tissue Regenix Group General Information

Description

Tissue Regenix Group PLC is a player in the field of biotechnology. It is a medical technology company engaged in the development of regenerative products. The company incorporates dcell technology, which helps to address complex and varying clinical needs. The company has operations worldwide, with special emphasis in the United States.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Stock Exchange
LON
Primary Office
  • Unit 1 & 2
  • Astley Way, Swillington
  • Leeds LS26 8XT
  • England, United Kingdom
+44 0330 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Tissue Regenix Group Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$58.6M 7.03B 17.7M

Tissue Regenix Group Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 60,071 37,893 9,291 80,022
Revenue 18,207 16,445 16,628 15,493
EBITDA (10,754) (11,498) (7,767) (10,022)
Net Income (12,147) (12,446) (8,897) (10,916)
Total Assets 47,482 50,058 39,984 47,791
Total Debt 7,432 7,246 2,997 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Tissue Regenix Group Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Tissue Regenix Group‘s full profile, request access.

Request a free trial

Tissue Regenix Group Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Tissue Regenix Group PLC is a player in the field of biotechnology. It is a medical technology company engaged in the de
Biotechnology
Leeds, United Kingdom
77 As of 2020
00000
00000000 00000

0000 000

sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna a
0000000000000
Burlington, MA
0 As of 0000
000.00
000000000 000.00

00000000

r in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint oc
0000000000000
Canton, MA
000 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tissue Regenix Group Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bone Biologics Corporation Burlington, MA 0 000.00 000000000 000.00
0000000000000 0000 Corporation Canton, MA 000 00000 00000000 00000
00000000 Formerly VC-backed Solana Beach, CA 0 0000 000000&0
00000000 Formerly VC-backed Schlieren, Switzerland 00 000.00 0000 000.00
00000000 00000000 Corporate Backed or Acquired Jacksonville, FL 000000&0
You’re viewing 5 of 5 competitors. Get the full list »

Tissue Regenix Group Executive Team (15)

Name Title Board Seat Contact Info
Daniel Lee Chief Executive Officer & Board Member
Greg Bila President, Tissue Regenix USA
Eileen Ingham Co-Founder
John Fisher Co-Founder
Patti Gary Vice President, Clinical Affairs
You’re viewing 5 of 15 executive team members. Get the full list »

Tissue Regenix Group Board Members (14)

Name Representing Role Since
Daniel Lee Tissue Regenix Group Chief Executive Officer & Board Member 000 0000
Jonathan Glenn Tissue Regenix Group Chairman & Board Member 000 0000
Randeep Grewal Tissue Regenix Group Board Member and Non-Executive Director 000 0000
Shervanthi Homer Vanniasinkam Tissue Regenix Group Board Member 000 0000
Trevor Phillips Ph.D Self Board Member 000 0000
You’re viewing 5 of 14 board members. Get the full list »

Tissue Regenix Group Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tissue Regenix Group Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Tissue Regenix Group‘s full profile, request access.

Request a free trial

Tissue Regenix Group Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 21-Jul-2017 000000000000000000 000.00 Biotechnology 000000 00000
000-0 0000000ü0000 27-Jan-2016 00000 0000000 Hospitals/Inpatient Services 000000 00000
Oxeco 30-Jun-2010 Merger/Acquisition Other Healthcare Services 0000 000000
To view Tissue Regenix Group’s complete investments and acquisitions history, request access »

Tissue Regenix Group Subsidiaries (1)

Company Name Industry Location Founded
000000000 Biotechnology Universal City, TX 0000
To view Tissue Regenix Group’s complete subsidiaries history, request access »